Literature DB >> 17290156

The risk for fractures after curettage and cryosurgery around the knee.

Tamir Pritsch1, Jacob Bickels, Chia-Chun Wu, Hart M Squires, Martin M Malawer.   

Abstract

Curettage and cryosurgery have been used successfully for treatment of benign locally aggressive and some low-grade malignant bone tumors. After treating these lesions, we reconstruct residual bone defects around the knee with cement, intramedullary pins, and autogenous bone graft for subchondral augmentation and closure of cortical windows. We questioned the incidence of fractures and the rates of nonunion and malunion and asked whether patients at risk for fractures can be identified. We conducted chart and radio-graphic reviews of 60 consecutive patients who had curettage and cryosurgery of primary bone lesions in the distal femur or proximal tibia. Ten of the 60 patients (17%) sustained postoperative intraarticular fractures. Patients who sustained fractures had (1) more freeze-thaw cycles; (2) metaphyseal defect ratios greater than 0.6 and 0.8 on the anteroposterior and lateral projections, respectively; and (3) 4 mm or less proximity of the defect to the joint. Only one fracture united in good alignment. Radiographic measurements can assist in identifying patients at risk for fractures after curettage and cryosurgery around the knee. We expect the fracture rate to decline by reducing the number of freeze-thaw cycles and improving our reconstruction method.

Entities:  

Mesh:

Year:  2007        PMID: 17290156     DOI: 10.1097/BLO.0b013e318038fc3d

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

1.  Cryosurgery/cryoablation in musculoskeletal neoplasms: history and state of the art.

Authors:  Peter S Rose; Jonathan M Morris
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

2.  Risk factors of fracture following curettage for bone giant cell tumors of the extremities.

Authors:  Shinji Tsukamoto; Andreas F Mavrogenis; Manabu Akahane; Kanya Honoki; Akira Kido; Yasuhito Tanaka; Davide Maria Donati; Costantino Errani
Journal:  BMC Musculoskelet Disord       Date:  2022-05-19       Impact factor: 2.562

3.  Grade I chondrosarcoma of bone: the Münster experience.

Authors:  Arne Streitbürger; Helmut Ahrens; Maurice Balke; Horst Buerger; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

4.  Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.

Authors:  Joseph Benevenia; Steven M Rivero; Jeffrey Moore; Joseph A Ippolito; Daniel A Siegerman; Kathleen S Beebe; Francis R Patterson
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

Review 5.  Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.

Authors:  S S Shemesh; J D Acevedo-Nieves; J Pretell-Mazzini
Journal:  Musculoskelet Surg       Date:  2017-10-06

6.  Excisional Curettage of Benign Cystic Lesions.

Authors:  Izuchukwu K Ibe; Kareme D Alder; Shasta E Henderson; Kristin E Yu; Francis Y Lee
Journal:  JBJS Essent Surg Tech       Date:  2019-07-10

7.  Tissue engineering for bone production- stem cells, gene therapy and scaffolds.

Authors:  E G Khaled; M Saleh; S Hindocha; M Griffin; Wasim S Khan
Journal:  Open Orthop J       Date:  2011-07-28

Review 8.  Postoperative complications with cryotherapy in bone tumors.

Authors:  Clark Chen; John Garlich; Katie Vincent; Earl Brien
Journal:  J Bone Oncol       Date:  2017-04-06       Impact factor: 4.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.